CDH1 and invasive ductal breast carcinoma: However, recent studies showed that 21% of invasive ductal carcinomas also exhibited the CN loss of CDH1 and 27% of high-grade invasive ductal carcinomas exhibited reduced or loss of E-cadherin membranous expression [23].